Stock listing

TG1N Stock Price, News, Filings & Events — Armata Pharmaceuticals, Inc.

Selected listing: TG1N · SWB · EUR · DE

This page tracks Armata Pharmaceuticals, Inc.'s TG1N:SWB listing on SWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TG1N:SWB. TG1N:SWB is the stock-level entry point for investors researching Armata Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Armata Pharmaceuticals, Inc. (ticker: ARMP) is a public company based in the United States, focusing on innovative therapies for bacterial infections. With a market capitalization of approximately $165.6 million, Armata is dedicated to advancing its pipeline of treatments aimed at addressing unmet medical needs in infectious diseases. The company is committed to developing solutions that improve patient outcomes and combat...

TG1N:SWBEURDEUpdated September 12, 2026
Armata Pharmaceuticals, Inc. logo
Ticker
TG1N:SWB
Asset type
Stock
Market cap
$200.0M
Sector
Health Technology
Industry
Biotechnology
Exchange
SWB
Currency
EUR

Armata Pharmaceuticals, Inc. TG1N:SWB stock context

This page tracks Armata Pharmaceuticals, Inc.'s TG1N:SWB listing on SWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TG1N:SWB. TG1N:SWB is the stock-level entry point for investors researching Armata Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Armata Pharmaceuticals, Inc. (ticker: ARMP) is a public company based in the United States, focusing on innovative therapies for bacterial infections. With a market capitalization of approximately $165.6 million, Armata is dedicated to advancing its pipeline of treatments aimed at addressing unmet medical needs in infectious diseases. The company is committed to developing solutions that improve patient outcomes and combat...

Latest news from Armata Pharmaceuticals, Inc.

All Armata Pharmaceuticals, Inc. news →

Research Armata Pharmaceuticals, Inc.

Alternate listings